CRI completes high-luxury repositioning; targets €500m revenue and €50m EBITDA by 2027
The company says its high-luxury repositioning is complete and reports strong H1 2026 sales momentum and profitability gains. Net profit rose to €24 million, driven by the Novacel sale, and it targets €500 million revenue and €50 million EBITDA by 2027.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.